öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÍõÖ¾Óî
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º578

ËùÊôԺУ£º¹ãÖÝÖÐÒ½Ò©´óѧ
ËùÊôԺϵ£º212µÚ¶þÁÙ´²Ò½Ñ§Ôº
Ö°³Æ£ºÖ÷ÈÎҽʦ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º ѧ¿ÆÁìÓò
ÖÐÎ÷Ò½½áºÏ»ù´¡
Ñо¿ÁìÓò£º ѧ¿ÆÁìÓò
ÖÐÎ÷Ò½½áºÏ»ù´¡ [ÊÕÆð]




¸öÈ˼òÊö :
¸öÈ˼òÊö
1981Äê11Ô³öÉú£¬½­ËÕÐìÖÝ£¬ºº×壬Öй²²úµ³Ô±£¬Ïã¸Û´óѧ²©Ê¿/²©Ê¿ºó£¬½ÌÓý²¿³¤½­Ñ§ÕßͨѶÆÀÉóר¼Ò¡¢¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð/¹ã¶«Ê¡×ÔÈ»¿Æѧ»ù½ð/½­ËÕÊ¡×ÔÈ»¿Æѧ»ù½ðÆÀÉóר¼Ò£»
Ö÷ÒªÈÙÓþ
¹ã¶«Ê¡ÌØÖ§¼Æ»®°ÙǧÍò¹¤³ÌÇàÄê°Î¼âÈ˲Å
¹ã¶«Ê¡×ÔÈ»¿Æѧ½Ü³öÇàÄê
Öé½­¿Æ¼¼ÐÂÐÇ
¹ã¶«Ê¡ÖÐÒ½Ôº°Î¼âÈ˲Å

¿ÆÑй¤×÷ :
¹¤×÷¾­Àú
2012-2014Ïã¸Û´óѧÀî¼Î³ÏҽѧԺ£¬²©Ê¿ºó
2015-ÖÁ½ñ¹ã¶«Ê¡ÖÐÒ½Ôº£¬Ñо¿Ô±£¬Ö÷ÈÎҽʦ
ѧÊõ¼æÖ°
ÊÀ½çÖÐҽҩѧ»áÁªºÏ»áÖÐҩϵͳ¿ÆѧÓ빤³ÌöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á³£ÎñÀíÊÂ
¹ú¼ÊÖÐÒ½Ò©Ö×ÁöÁªÃËίԱ
ÃÀ¹úAACR»áÔ±
¹ã¶«Ê¡ÖÐҽҩѧ»áÖÐÒ½Ò©·ÀÖÎÈéÏÙ²¡·Ö»áίԱ
¹ã¶«Ê¡¾«×¼Ò½Ñ§Ó¦ÓÃѧ»á¸Î²¡·Ö»áίԱ
½ÌÓý²¿³¤½­Ñ§ÕßͨѶÆÀÉóίԱ»á
¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðͨѶÆÀÒéר¼Ò
¹ã¶«Ê¡/½­ËÕÊ¡/ËÄ´¨Ê¡/ºÓ±±Ê¡×ÔÈ»¿Æѧ»ù½ðÆÀÒéר¼Ò
¡¶AnalyticalCellularPathology¡·ÌØ¿¯Ö÷±à
Ö÷ÒªÂÛÎÄ
1.WangZ*,WangN,WangS,ZhengY.Caveolin-1inhibitsmammarycarcinogenesisviasuppressingc-myc-inducedmetabolismreprogramminginbreastcancerstemcells.CancerResearch,2017,DOI:10.1158/1538-7445.(*Correspondingauthor,IF=9.122)
2.WangS,WangN,ZhengY,ZhangJ,ZhangF,WangZ*.Caveolin-1:AnOxidativeStress-RelatedTargetforCancerPrevention.OxidMedCellLongev.**:**.(*Correspondingauthor,IF=4.492)
3.WangZ*,WangN,LiuX,WangQ,XuB,LiuP,ZhuH,ChenJ,SituHL,LinY.BroadleafMahoniaattenuatesgranulomatouslobularmastitis-associatedinflammationbyinhibitingCCL-5expressioninmacrophages.InternationalJournalofMolecularMedicine,2017,Accept.(*Correspondingauthor,IF=2.348)
4.WangZhiyu*,WangNeng,WangQ,PengC,ZhangJ,LiuP,OuA,ZhongS,CorderoMD,LinY.Theinflammasome:anemergingtherapeutictargetforcancerprevention.Oncotarget,2016,7(31):50766-50780.(*Correspondingauthor,IF=5.008)
5.WangZhiyu*,WangNeng,LiuPengxi,PengFu,TangHailin,ChenQianjun,XuRui,DaiYan,LinYi,XieXiaoming,PengCheng,SituHonglin.Caveolin-1,astress-relatedoncotarget,indrugresistance.Oncotarget,2015,6(35):37135-50.(*Correspondingauthor,IF=6.359)
6.WangZhiyu*,LiuPengxi,ChenQianjun,DengShigui,LiuXiaoyan,SituHL,ZhongShaowen,HannShouwei,LinYi.TargetingAMPKsignalingpathwaytoovercomedrugresistanceforcancertherapy.CurrentDrugTargets,2015,17(8):853-64(*Correspondingauthor,IF=3.597)
7.WangNeng#,WangZhiyu#,WangYu,XieXiaoming,ShenJiangang,PengCheng,YouJieshu,PengFu,TangHailin,GuanXinyuan,ChenJianping*.DietaryCompoundIsoliquiritigeninpreventsmammarycarcinogenesisbyinhibitingbreastcancerstemcellsthroughWIF-1demethylation.Oncotarget,2015,6(12):9854-76(#co-firstauthor)(IF=6.627).
8.WangZhiyu,WangNeng,LiWenping,LiuPengxi,ChenQianjun,SituHonglin,ZhongShaowen,GuoLi,LinYi,ShenJiangang,ChenJianping.Caveolin-1mediateschemoresistanceofbreastcancerstemcellsvia¦Â-catenin/ABCG2signalingpathway.Carcinogenesis,2014,35(10):2346-2356.(IF=5.266)
9.WangZhiyu,WangNeng,LiuPengxi,ChenQianjun,SituHonglin,Xieting,ZhangJianxing,PengCheng,LinYi,ChenJianping.MicroRNA-25regulatesautophagyassociatedwithchemoresistanceofbreastcancercells:aprocessmodulatedbynaturalautophagyinducerisoliquiritigenin.Oncotarget,2014,5(16):7013-7026.(IF=6.627)
10.WangNeng#,WangZhiyu#,PengCheng,YouJieshu,ShenJiangang,HanShouwei,ChenJianping.DietarycompoundisoliquiritigenintargetsGRP78tochemosensitizebreastcancerstemcellsvia¦Â-catenin/ABCG2signaling.Carcinogenesis,2014,35(11):2544-2554.(#co-firstauthor)(IF=5.266)
11.WangZhiyu#,WangNeng#,HanShouwei,WangDongmei,MoSuilin,YuLinzhong,HuangHui,TsuiKamchuen,ShenJiangang,ChenJianping.DietarycompoundIsoliquiritigenininhibitsbreastcancergrowthandneoangiogenesisviablockingVEGF/VEGFR-2signalingpathway.Plosone,2013,8(7):e68566.(IF=3.534)
12.WangZhiyu,WangDongmei,HanShouwei,WangNeng,MoFeizhi,LooTjingyung,ShenJiangang,Huanghui,ChenJianping.Bioactivityguidedfractionationandcellsignalingtechnologytodelinatethelactatedehydrogenaseinhibitioneffectsofspatholobussuberectusonbreastcancer.Plosone,2013,8(2):e56631.(IF=3.534)
13.WangZhiyu,LooTjingYung,ShenJiangang,WangNeng,WangDongmei,YangDepo,MoSuilin,GuanXinyuan,ChenJianping.LDH-Asilencingsuppressesbreastcancertumorigenicitythroughinductionofoxidativestressmediatedmitochondrialpathwayapoptosis.BreastCancerResearchandTreatment,2012,131(3):791-800.(IF=4.198)
14.WangZhiyu,LooWingsTY,WangNeng,ChowWCLouis,WangDongmei,HanFeng,ZhengXiao,ChenJianping.EffectofSanguisorbaofficinalisLonbreastcancergrowthandangiogenesis.ExpertOpiniononTherapeuticTargets,2012,Suppl1:S79-89.(IF=4.901)
15.WangZhiyu,ChengYue,WangNeng,WangDongmei,LiYingwei,HanFeng,ShenJiangang,YangDepo,GuanXinyuan,ChenJianping.Dioscininducescancercellapoptosisthroughelevatedoxidativestressmediatedbydownregulationofperoxiredoxins.CancerBiology&Therapy,2012,13(3):138-147.(IF=3.63)
16.WangZhiyu,WangNeng,ChenJianping,ShenJiangang.EmergingGlycolysisTargetingandDrugDiscoveryfromChineseMedicineinCancerTherapy.EvidenceBasedComplementaryandAlternativeMedicine,2012,2012:873175.(IF=2.175)
17.WangZhiyu,WangDongmei,LooTjingYung,ChengYue,ChenLeilei,ShenJiangang,YangDepo,ChowLouisWing-Cheong,GuanXinyuan,ChenJianping.SpatholobussuberectusinhibitscancercellgrowthbyinducingapoptosisandarrestingcellcycleatG2/Mcheckpoint.JournalofEthnopharmacology,2011,133(2):751-758.(IF=2.939)

½ÌÓý±³¾° :
2005Äê±ÏÒµÓÚÎ÷°²½»Í¨´óѧҽѧԺ£¬»ñÁÙ´²Ò½Ñ§Ñ§Ê¿Ñ§Î»¡£
2008Äê±ÏÒµÓÚÎ÷°²½»Í¨´óѧÑо¿ÉúÔº£¬»ñÖ×Áöѧ˶ʿѧλ¡£
2012Äê±ÏÒµÓÚÏã¸Û´óѧÀî¼Î³ÏҽѧԺ£¬»ñ²©Ê¿Ñ§Î»¡£